Relation of natriuretic peptide concentrations to central sleep apnea in patients with heart failure

Chest

Volumn 140, Issue 6, 2011, Pages 1517-1523

  Calvin, Andrew D ^a   Somers, Virend K ^a   Van Der Walt, Christelle ^a   Scott, Christopher G ^a,b   Olson, Lyle J ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; APNEA HYPOPNEA INDEX; AREA UNDER THE CURVE; ARTICLE; CENTRAL SLEEP APNEA SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; POLYSOMNOGRAPHY; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SEX DIFFERENCE;

EID: 83455201043     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-2472     Document Type: Article

References (50)

1. Oldenburg O, Bitter T, Wiemer M, Langer C, Horstkotte D, Piper C. Pulmonary capillary wedge pressure and pulmonary arterial pressure in heart failure patients with sleep-disordered breathing. Sleep Med. 2009;10(7):726-730.
2. Solin P, Bergin P, Richardson M, Kaye DM, Walters EH, Naughton MT. Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation. 1999; 99 (12):1574-1579. (Pubitemid 29152924)
3. Lanfranchi PA, Braghiroli A, Bosimini E, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation. 1999;99(11):1435-1440. (Pubitemid 29140908)
4. Hanly PJ, Zuberi-Khokhar NS. Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med. 1996; 153 (1):272- 276.
5. Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation. 1998;97(21):2154-2159. (Pubitemid 28262123)
6. Philippe C, Stoïca-Herman M, Drouot X, et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne- Stokes respiration in heart failure over a six month period. Heart. 2006;92(3):337-342.
7. Szollosi I, O'Driscoll DM, Dayer MJ, Coats AJ, Morrell MJ, Simonds AK. Adaptive servo-ventilation and deadspace:effects on central sleep apnoea. J Sleep Res. 2006; 15 (2):199- 205.
8. Kasai T, Narui K, Dohi T, et al. First experience of using new adaptive servo-ventilation device for Cheyne-Stokes respiration with central sleep apnea among Japanese patients with congestive heart failure:report of 4 clinical cases. Circ J. 2006;70(9):1148-1154. (Pubitemid 44386995)
9. Teschler H, Döhring J, Wang YM, Berthon-Jones M. Adaptive pressure support servo-ventilation:a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med. 2001;164(4):614-619. (Pubitemid 32801665)
10. Noda A, Izawa H, Asano H, et al. Beneficial effect of bilevel positive airway pressure on left ventricular function in ambulatory patients with idiopathic dilated cardiomyopathy and central sleep apnea-hypopnea:a preliminary study. Chest. 2007;131(6):1694-1701. (Pubitemid 46981622)
11. Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin F, Bradley TD. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med. 1995;152(2):473-479.
12. Arzt M, Floras JS, Logan AG, et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure-a post hoc analysis of CANPAP. Circulation. 2007;115(25):3140-3142.
13. Heart Failure Society of America. Executive Summary:HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2010;16(6):475-539.
14. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update:ACCF/AHA Guidelines for the Diagnosis and Man agement of Heart Failure in Adults:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines:developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119(14):1977-2016.
15. Dickstein K, Cohen-Solal A, Filippatos G, et alTask Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology;ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) [published corrections appear in Eur Heart J. 2010;12(4):416 and Eur Heart J. 2010;31(5):624]. Eur Heart J. 2008;29(19):2388-2442.
16. Sin DD, Fitzgerald FS, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med. 1999;160(4):1101-1106. (Pubitemid 29487445)
17. Garcia-Touchard A, Somers VK, Olson LJ, Caples SM. Central sleep apnea:implications for congestive heart failure. Chest. 2008;133(6):1495-1504. (Pubitemid 351893011)
18. Bradley TD, Floras JS. Sleep apnea and heart failure:part II:central sleep apnea. Circulation. 2003;107(13):1822-1826. (Pubitemid 36418366)
19. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure:analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 2002;106(4):416-422. (Pubitemid 34803684)
20. Lainchbury JG, Campbell E, Frampton CM, Yandle TG, Nicholls MG, Richards AM. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol. 2003;42(4):728-735. (Pubitemid 37000195)
21. Maisel AS, Krishnaswamy P, Nowak RM, et alBreathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161-167. (Pubitemid 34764819)
22. Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure:systematic review. BMJ. 2005;330(7492):625-634.
23. Porapakkham P, Porapakkham P, Zimmet H, Billah B, Krum H. B-type natriuretic peptide-guided heart failure therapy:a meta-analysis. Arch Intern Med. 2010;170(6):507-514.
24. Jarolim P. Serum biomarkers for heart failure. Cardiovasc Pathol. 2006;15(3):144-149. (Pubitemid 43669075)
25. Lorenzi-Filho G, Azevedo ER, Parker JD, Bradley TD. Relationship of carbon dioxide tension in arterial blood to pulmonary wedge pressure in heart failure. Eur Respir J. 2002;19 (1):37-40. (Pubitemid 34105565)
26. Li H, Oparil S, Meng QC, Elton TS, Chen YF. Selective down-regulation of ANP-clearance-receptor gene expression in lung of rats adapted to hypoxia. Am J Physiol. 1995;268(2 pt 1):L328- L335.
27. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.
28. Iber C, Ancoli-Israel S, Chesson A, Quan SF;for the American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events:Rules, Terminology, and Technical Specifications. 1st ed. Westchester, Illinois :American Academy of Sleep Medicine;2007.
29. Yumino D, Wang H, Floras JS, et al. Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction. J Card Fail. 2009;15(4):279-285.
30. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994;90(1):195-203. (Pubitemid 24203680)
31. Chun Y-S, Hyun J-Y, Kwak Y-G, et al. Hypoxic activation of the atrial natriuretic peptide gene promoter through direct and indirect actions of hypoxia-inducible factor-1. Biochem J. 2003;370(pt 1):149-157. (Pubitemid 36259427)
32. Chen Y-F, Durand J, Claycomb WC. Hypoxia stimulates atrial natriuretic peptide gene expression in cultured atrial cardiocytes. Hypertension. 1997;29(1 pt 1):75-82. (Pubitemid 27078345)
33. Baertschi AJ, Hausmaninger C, Walsh RS, Mentzer RM Jr, Wyatt DA, Pence RA. Hypoxia-induced release of atrial natriuretic factor (ANF) from the isolated rat and rabbit heart. Biochem Biophys Res Commun. 1986;140(1):427-433. (Pubitemid 17190041)
34. Baertschi AJ, Adams JM, Sullivan MP. Acute hypoxemia stimulates atrial natriuretic factor secretion in vivo. Am J Physiol. 1988;255(2 pt 2):H295-H300.
35. Baertschi AJ, Teague WG. Alveolar hypoxia is a powerful stimulus for ANF release in conscious lambs. Am J Physiol. 1989;256(4 pt 2):H990-H998.
36. Tóth M, Vuorinen KH, Vuolteenaho O, et al. Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium. Am J Physiol. 1994;266(4 pt 2):H1572-H1580.
37. Perhonen M, Takala TE, Vuolteenaho O, Mantymaa P, Leppaluoto J, Ruskoaho H. Induction of cardiac natriuretic peptide gene expression in rats trained in hypobaric hypoxic conditions. Am J Physiol. 1997;273(1 pt 2):R344-R352.
38. Weidemann A, Klanke B, Wagner M, et al. Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1alpha, is a direct and sufficient stimulus for brain-type natriuretic peptide induction. Biochem J. 2008;409(1):233-242.
39. Hama N, Itoh H, Shirakami G, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation. 1995;92(6):1558-1564.
40. He Q, Wang D, Yang X-P, Carretero OA, LaPointe MC. Inducible regulation of human brain natriuretic peptide promoter in transgenic mice. Am J Physiol Heart Circ Physiol. 2001;280(1):H368-H376.
41. Hill NS, Klinger JR, Warburton RR, Pietras L, Wrenn DS. Brain natriuretic peptide:possible role in the modulation of hypoxic pulmonary hypertension. Am J Physiol. 1994;266(3 pt 1):L308-L315.
42. Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N Engl J Med. 1999;341(13):949-954. (Pubitemid 29441549)
43. Carmona-Bernal C, Quintana-Gallego E, Villa-Gil M, Sánchez- Armengol A, Martínez-Martínez A, Capote F. Brain natriuretic peptide in patients with congestive heart failure and central sleep apnea. Chest. 2005;127(5):1667-1673. (Pubitemid 46218793)
44. Christ M, Sharkova Y, Fenske H, et al. Brain natriuretic peptide for prediction of Cheyne-Stokes respiration in heart failure patients. Int J Cardiol. 2007;116(1):62-69. (Pubitemid 46237670)
45. Hunt SA, Abraham WT, Chin MH, et al. American College of Cardiology;American Heart Association Task Force on Practice Guidelines;American College of Chest Physicians;International Society for Heart and Lung Transplantation;Heart Rhythm Society. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult:a report f the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure):developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplan tation:endorsed by the Heart Rhythm Society. Circulation. 2005; 112 (12):e154- e235.
46. Bitter T, Faber L, Hering D, Langer C, Horstkotte D, Oldenburg O. Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction. Eur J Heart Fail. 2009;11(6):602-608.
47. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration:impact of age and gender. J Am Coll Cardiol. 2002;40(5):976-982. (Pubitemid 34994995)
48. Koshino Y, Villarraga HR, Orban M, et al. Changes in left and right ventricular mechanics during the Mueller maneuver in healthy adults:a possible mechanism for abnormal cardiac function in patients with obstructive sleep apnea. Circ Cardiovasc Imaging. 2010;3(3):282-289.
49. Orban M, Bruce CJ, Pressman GS, et al. Dynamic changes of left ventricular performance and left atrial volume induced by the mueller maneuver in healthy young adults and implications for obstructive sleep apnea, atrial fibrillation, and heart failure. Am J Cardiol. 2008;102(11):1557-1561.
50. Svatikova A, Shamsuzzaman AS, Wolk R, Phillips BG, Olson LJ, Somers VK. Plasma brain natriuretic peptide in obstructive sleep apnea. Am J Cardiol. 2004;94(4):529-532. (Pubitemid 39120013)